News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

All Eyes Are on Pfizer (PFE) As Speculation Brews For Next Potential M&A



8/7/2017 7:58:24 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
As promised, Pfizer Inc (PFE) reported quarterly earnings during pre-market, but the anticipated release failed to impress after the pharmaceutical company didn't maintain expectations.

Revenue missed Wall Street projections, dipping 2% from $13.15 billion to $12.9 billion. Pfizer fell 0.86% in Monday morning trading to $33.35 a share.

"Every time I see the Pfizer quarter I recognize why they needed to do the Allergan [plc] (AGN) deal," said Jim Cramer, TheStreet's founder and portfolio manager of Action Alerts PLUS Charitable Trust.

Read at The Street.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES